Back to Search Start Over

Factor VIII-Fc Activates Natural Killer Cells

Authors :
H A Daniel, Lagassé
Louis B, Hopkins
Wojciech, Jankowski
Marc G, Jacquemin
Zuben E, Sauna
Basil, Golding
Source :
Frontiers in Immunology
Publication Year :
2021

Abstract

The most challenging complication associated with Factor VIII (FVIII) replacement therapy is the development of neutralizing anti-drug antibodies, or inhibitors, which occur in 23-35% of severe (FVIII level

Details

ISSN :
16643224
Volume :
12
Database :
OpenAIRE
Journal :
Frontiers in immunology
Accession number :
edsair.pmid..........2152f6f7e18201db95585f798e4faeb4